Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research CollaborationRelease Date:Call for Collaborator(s) Vaccines France, Germany Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Title Grant Type Focus Area Country Application Due Date Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe ProgramRelease Date:Implementation of MenB Vaccine Recommendations in Older Adolescents/Young AdultsRelease Date:Rheumatology FellowshipsRelease Date:Release Date:Review Process:IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric DrugsRelease Date:Pfizer and American Pain Society: Improving Chronic Pain CareRelease Date:Accelerating Improvements in Medication OptimizationRelease Date:Review Process:Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia PatientsRelease Date:Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke RiskRelease Date:IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-releaseRelease Date:Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision MakingRelease Date:Review Process:IBD Fellowship RFP 12212016Release Date: